Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Protagenic Therapeutics Inc. (PTIXW)

  • Technical Exchange News
  • May 31, 2024, 02:09 UTC
  • 38
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Gossamer Bio Inc (GOSS)

  • Technical Exchange News
  • May 31, 2024, 02:09 UTC
  • 38
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

BioRestorative Therapies Inc (BRTX)

  • Technical Exchange News
  • May 31, 2024, 02:09 UTC
  • 39
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

Burning Rock Biotech Ltd (BNR)

  • Technical Exchange News
  • May 31, 2024, 02:09 UTC
  • 41
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Inhibrx (INBX)

  • Technical Exchange News
  • May 31, 2024, 01:05 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Inhibrx, Inc. - Common Stock. New value: Inhibrx Biosciences, Inc. - Common Stock.

Comment Full text

Vincerx Pharma Inc. (VINC)

  • Technical Exchange News
  • May 30, 2024, 19:02 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Protagenic Therapeutics Inc. (PTIX)

  • Technical Exchange News
  • May 30, 2024, 19:01 UTC
  • 37
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Protagenic Therapeutics Inc. (PTIXW)

  • Technical Exchange News
  • May 30, 2024, 19:01 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Gossamer Bio Inc (GOSS)

  • Technical Exchange News
  • May 30, 2024, 19:01 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

BioRestorative Therapies Inc (BRTX)

  • Technical Exchange News
  • May 30, 2024, 19:01 UTC
  • 40
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text
  • Previous
  • 662
  • 663
  • 664
  • 665
  • 666
  • Next

Search

News categories

  • Technical Exchange News(11766)
  • Event(4289)
  • SEC News(235886)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143341)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin